Lung cancer is the leading cause of cancer-related mortality in the United States and worldwide. Early detection of lung cancer is an important opportunity for decreasing mortality. Data support using low-dose computed tomography (LDCT) of the chest to screen select patients who are at high risk for lung cancer. Lung screening is covered under the Affordable Care Act for individuals with high-risk factors. The Centers for Medicare & Medicaid Services (CMS) covers annual screening LDCT for appropriate Medicare beneficiaries at high risk for lung cancer if they also receive counseling and participate in shared decision-making before screening. The complete version of the NCCN Guidelines for Lung Cancer Screening provides recommendations for initial and subsequent LDCT screening and provides more detail about LDCT screening. This manuscript focuses on identifying patients at high risk for lung cancer who are candidates for LDCT of the chest and on evaluating initial screening findings.

  • 1.

    TorreLASiegelRLWardEMJemalA. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev2016;25:1627.

    • Search Google Scholar
    • Export Citation
  • 2.

    TorreLABrayFSiegelRL. Global cancer statistics, 2012. CA Cancer J Clin2015;65:87108.

  • 3.

    The Health Consequences of Smoking: A Report of the Surgeon General (ed 2010/07/30). Atlanta: US Department of Health and Human Services; 2004.

    • Search Google Scholar
    • Export Citation
  • 4.

    ThunMJHenleySJBurnsD. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst2006;98:691699.

  • 5.

    JemalABrayFCenterMM. Global cancer statistics. CA Cancer J Clin2011;61:6990.

  • 6.

    SiegelRLMillerKDJemalA. Cancer statistics, 2018. CA Cancer J Clin2018;68:730.

  • 7.

    HowladerNNooneAMKrapchoM. SEER Cancer Statistics Review 1975–2014 based on November 2016 SEER data submission posted to the SEER web site April 2017. Bethesda, MD: National Cancer Institute; 2017.

    • Search Google Scholar
    • Export Citation
  • 8.

    JemalAWardEMJohnsonCJ. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst2017;109.

  • 9.

    JemalAThunMJRiesLA. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst2008;100:16721694.

    • Search Google Scholar
    • Export Citation
  • 10.

    National Lung Screening Trial Research TeamAberleDRBergCD. The National Lung Screening Trial: overview and study design. Radiology2011;258:243253.

    • Search Google Scholar
    • Export Citation
  • 11.

    National Lung Screening Trial Research TeamAberleDRAdamsAM. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med2011;365:395409.

    • Search Google Scholar
    • Export Citation
  • 12.

    AberleDRDeMelloSBergCD. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med2013;369:920931.

  • 13.

    National Lung Screening Trial Research TeamChurchTRBlackWC. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med2013;368:19801991.

    • Search Google Scholar
    • Export Citation
  • 14.

    KramerBSBergCDAberleDRProrokPC. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). J Med Screen2011;18:109111.

    • Search Google Scholar
    • Export Citation
  • 15.

    MidthunDE. Screening for lung cancer. Clin Chest Med2011;32:659668.

  • 16.

    MoyerVAForce USPST. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med2014;160:330338.

    • Search Google Scholar
    • Export Citation
  • 17.

    DetterbeckFCMazzonePJNaidichDPBachPB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest2013;143:e78S92S.

    • Search Google Scholar
    • Export Citation
  • 18.

    WoodDEEapenGAEttingerDS. Lung cancer screening. J Natl Compr Canc Netw2012;10:240265.

  • 19.

    WoodDE. Lung cancer screening: the last 10 years. J Natl Compr Canc Netw2012;10:13231325.

  • 20.

    KazerooniEAArmstrongMRAmorosaJK. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol2016;13:R3034.

    • Search Google Scholar
    • Export Citation
  • 21.

    McKeeBJRegisSMMcKeeABFlackeSWaldC. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol2016;13:R2529.

    • Search Google Scholar
    • Export Citation
  • 22.

    PinskyPFGieradaDSBlackW. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med2015;162:485491.

    • Search Google Scholar
    • Export Citation
  • 23.

    LeoneFTEvers-CaseySTollBAVachaniA. Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest2013;143:e61S77S.

    • Search Google Scholar
    • Export Citation
  • 24.

    FucitoLMCzabafySHendricksPS. Pairing smoking-cessation services with lung cancer screening: a clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer2016;122:11501159.

    • Search Google Scholar
    • Export Citation
  • 25.

    SitasFWeberMFEggerSYapSChiewMO'ConnellD. Smoking cessation after cancer. J Clin Oncol2014;32:35933595.

  • 26.

    TaylorKLCoxLSZinckeNMehtaLMcGuireCGelmannE. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer2007;56:125134.

    • Search Google Scholar
    • Export Citation
  • 27.

    CataldoJKDubeySProchaskaJJ. Smoking cessation: an integral part of lung cancer treatment. Oncology2010;78:289301.

  • 28.

    HaysJTMcFaddenDDEbbertJO. Pharmacologic agents for tobacco dependence treatment: 2011 update. Curr Atheroscler Rep2012;14:8592.

  • 29.

    WienerRSGouldMKArenbergDA. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med2015;192:881891.

    • Search Google Scholar
    • Export Citation
  • 30.

    MazzonePPowellCAArenbergD. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest2015;147:295303.

    • Search Google Scholar
    • Export Citation
  • 31.

    DavisAMCifuAS. Lung cancer screening. JAMA2014;312:12481249.

  • 32.

    FintelmannFJBernheimADigumarthySR. The 10 pillars of lung cancer screening: rationale and logistics of a lung cancer screening program. Radiographics2015;35:18931908.

    • Search Google Scholar
    • Export Citation
  • 33.

    ArmstrongKKimJJHalmEA. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer2016;122:13381342.

    • Search Google Scholar
    • Export Citation
  • 34.

    KazerooniEAAustinJHBlackWC. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J Thorac Imaging2014;29:310316.

    • Search Google Scholar
    • Export Citation
  • 35.

    McKeeBJRegisSMMcKeeAB. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol2015;12:273276.

  • 36.

    de KoningHJMezaRPlevritisSK. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med2014;160:311320.

    • Search Google Scholar
    • Export Citation
  • 37.

    WienerRSGouldMKWoloshinS. What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest. 2013;143:672677.

    • Search Google Scholar
    • Export Citation
  • 38.

    AberleDRAbtinFBrownK. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol2013;31:10021008.

    • Search Google Scholar
    • Export Citation
  • 39.

    GoulartBHRamseySD. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs. Oncologist2013;18:941946.

    • Search Google Scholar
    • Export Citation
  • 40.

    SoxHC. Implementing lung cancer screening under Medicare: the last chance to get it right?JAMA2014;312:12061207.

  • 41.

    VolkRJHawkEBeversTB. Should CMS cover lung cancer screening for the fully informed patient?JAMA2014;312:11931194.

  • 42.

    FieldJKSmithRAAberleDR. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol2012;7:1019.

    • Search Google Scholar
    • Export Citation
  • 43.

    BachPBMirkinJNOliverTK. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA2012;307:24182429.

  • 44.

    WalterJEHeuvelmansMAde JongPA. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol2016;17:907916.

    • Search Google Scholar
    • Export Citation
  • 45.

    FieldJKDuffySWBaldwinDR. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess2016;20:1146.

    • Search Google Scholar
    • Export Citation
  • 46.

    FieldJKDuffySWBaldwinDR. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax2016;71:161170.

    • Search Google Scholar
    • Export Citation
  • 47.

    PatzEFJr.GrecoEGatsonisC. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol2016;17:590599.

    • Search Google Scholar
    • Export Citation
  • 48.

    WilleMMDirksenAAshrafH. Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. Am J Respir Crit Care Med2016;193:542551.

    • Search Google Scholar
    • Export Citation
  • 49.

    HorewegNvan RosmalenJHeuvelmansMA. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol2014;15:13321341.

    • Search Google Scholar
    • Export Citation
  • 50.

    HorewegNScholtenETde JongPA. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol2014;15:13421350.

    • Search Google Scholar
    • Export Citation
  • 51.

    ProschHSchaefer-ProkopC. Screening for lung cancer. Curr Opin Oncol2014;26:131137.

  • 52.

    HorewegNvan der AalstCMThunnissenE. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med2013;187:848854.

    • Search Google Scholar
    • Export Citation
  • 53.

    McRonaldFEYadegarfarGBaldwinDR. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila)2014;7:362371.

    • Search Google Scholar
    • Export Citation
  • 54.

    FieldJKvan KlaverenRPedersenJH. European randomized lung cancer screening trials: post NLST. J Surg Oncol2013;108:280286.

  • 55.

    Ru ZhaoYXieXde KoningHJ. NELSON lung cancer screening study. Cancer Imaging2011;11Spec No A:S7984.

  • 56.

    XuDMGietemaHde KoningH. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer2006;54:177184.

  • 57.

    NairAHansellDM. European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol2011;21:24452454.

    • Search Google Scholar
    • Export Citation
  • 58.

    van IerselCAde KoningHJDraismaG. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer2007;120:868874.

    • Search Google Scholar
    • Export Citation
  • 59.

    PatzEFJr.PinskyPGatsonisC. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med2014;174:269274.

  • 60.

    ReichJM. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening. Thorax2008;63:377383.

    • Search Google Scholar
    • Export Citation
  • 61.

    BlackWC. Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer2007;110:23702384.

    • Search Google Scholar
    • Export Citation
  • 62.

    OkenMMHockingWGKvalePA. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA2011;306:18651873.

    • Search Google Scholar
    • Export Citation
  • 63.

    WenderRFonthamETBarreraEJr.. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin2013;63:107117.

  • 64.

    JaklitschMTJacobsonFLAustinJH. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg2012;144:3338.

    • Search Google Scholar
    • Export Citation
  • 65.

    RobertsHWalker-DilksCSivjeeK. Screening high-risk populations for lung cancer: guideline recommendations. J Thorac Oncol2013;8:12321237.

    • Search Google Scholar
    • Export Citation
  • 66.

    AlbergAJBrockMVFordJG. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest2013;143:e1S29S.

    • Search Google Scholar
    • Export Citation
  • 67.

    DriscollTNelsonDISteenlandK. The global burden of disease due to occupational carcinogens. Am J Ind Med2005;48:419431.

  • 68.

    de GrootPMundenRF. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am2012;50:863876.

  • 69.

    YouldenDRCrambSMBaadePD. The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol2008;3:819831.

    • Search Google Scholar
    • Export Citation
  • 70.

    JamalAKingBANeffLJ. Current cigarette smoking among adults - United States, 2005-2015. MMWR Morb Mortal Wkly Rep2016;65:12051211.

  • 71.

    JacobsEJNewtonCCCarterBD. What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking?Ann Epidemiol2015;25:179182 e171.

    • Search Google Scholar
    • Export Citation
  • 72.

    Centers for Disease Control and Prevention. Current cigarette smoking among adults—United States, 2011. MMWR Morb Mortal Wkly Rep2012;61:889894.

    • Search Google Scholar
    • Export Citation
  • 73.

    JhaPPetoR. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med2014;370:6068.

  • 74.

    ChenLSBakerTHungRJ. Genetic risk can be decreased: quitting smoking decreases and delays lung cancer for smokers with high and low CHRNA5 risk genotypes - a meta-analysis. EBioMedicine2016;11:219226.

    • Search Google Scholar
    • Export Citation
  • 75.

    HechtSS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst1999;91:11941210.

  • 76.

    SecretanBStraifKBaanR. A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol2009;10:10331034.

    • Search Google Scholar
    • Export Citation
  • 77.

    SakodaLCLoomisMMDohertyJA. Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. Int J Mol Epidemiol Genet2012;3:117.

    • Search Google Scholar
    • Export Citation
  • 78.

    Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep2008;57:12261228.

    • Search Google Scholar
    • Export Citation
  • 79.

    JhaPRamasundarahettigeCLandsmanV. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med2013;368:341350.

    • Search Google Scholar
    • Export Citation
  • 80.

    DollRPetoRBorehamJSutherlandI. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ2004;328:1519.

  • 81.

    MoolgavkarSHHolfordTRLevyDT. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst2012;104:541548.

    • Search Google Scholar
    • Export Citation
  • 82.

    PetoRDarbySDeoH. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ2000;321:323329.

    • Search Google Scholar
    • Export Citation
  • 83.

    KaszaKAAmbroseBKConwayKP. Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med2017;376:342353.

    • Search Google Scholar
    • Export Citation
  • 84.

    HuSSNeffLAgakuIT. Tobacco product use among adults - United States, 2013-2014. MMWR Morb Mortal Wkly Rep2016;65:685691.

  • 85.

    Office on Smoking and Health (US). The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General (ed 2010/07/30). Atlanta: Centers for Disease Control and Prevention; 2006.

    • Search Google Scholar
    • Export Citation
  • 86.

    GarfinkelL. Time trends in lung cancer mortality among nonsmokers and a note on passive smoking. J Natl Cancer Inst1981;66:10611066.

    • Search Google Scholar
    • Export Citation
  • 87.

    HackshawAKLawMRWaldNJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ1997;315:980988.

  • 88.

    DelvaFMargeryJLaurentF. Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations. BMC Public Health2017;17:191.

    • Search Google Scholar
    • Export Citation
  • 89.

    StraifKBenbrahim-TallaaLBaanR. A review of human carcinogens--part C: metals, arsenic, dusts, and fibres. Lancet Oncol2009;10:453454.

    • Search Google Scholar
    • Export Citation
  • 90.

    SilvermanDTSamanicCMLubinJH. The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst2012;104:855868.

    • Search Google Scholar
    • Export Citation
  • 91.

    NelsonDIConcha-BarrientosMDriscollT. The global burden of selected occupational diseases and injury risks: methodology and summary. Am J Ind Med2005;48:400418.

    • Search Google Scholar
    • Export Citation
  • 92.

    NurminenMKarjalainenA. Epidemiologic estimate of the proportion of fatalities related to occupational factors in Finland. Scand J Work Environ Health2001;27:161213.

    • Search Google Scholar
    • Export Citation
  • 93.

    SteenlandKLoomisDShyCSimonsenN. Review of occupational lung carcinogens. Am J Ind Med1996;29:474490.

  • 94.

    MarkowitzSBLevinSMMillerAMorabiaA. Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. Am J Respir Crit Care Med2013;188:9096.

    • Search Google Scholar
    • Export Citation
  • 95.

    FrostGDarntonAHardingAH. The effect of smoking on the risk of lung cancer mortality for asbestos workers in Great Britain (1971-2005). Ann Occup Hyg2011;55:239247.

    • Search Google Scholar
    • Export Citation
  • 96.

    ReidAde KlerkNHAmbrosiniGL. The risk of lung cancer with increasing time since ceasing exposure to asbestos and quitting smoking. Occup Environ Med2006;63:509512.

    • Search Google Scholar
    • Export Citation
  • 97.

    El GhissassiFBaanRStraifK. A review of human carcinogens--part D: radiation. Lancet Oncol2009;10:751752.

  • 98.

    LeuraudKSchnelzerMTomasekL. Radon, smoking and lung cancer risk: results of a joint analysis of three European case-control studies among uranium miners. Radiat Res2011;176:375387.

    • Search Google Scholar
    • Export Citation
  • 99.

    LubinJHBoiceJDJr.Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst1997;89:4957.

    • Search Google Scholar
    • Export Citation
  • 100.

    DarbySHillDAuvinenA. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ2005;330:223.

    • Search Google Scholar
    • Export Citation
  • 101.

    WuGXNelsonRAKimJYRazDJ. Non-small cell lung cancer as a second primary among patients with previous malignancy: who is at risk?Clin Lung Cancer2017;18:543550.

    • Search Google Scholar
    • Export Citation
  • 102.

    TuckerMAMurrayNShawEG. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst1997;89:17821788.

    • Search Google Scholar
    • Export Citation
  • 103.

    ShielsMSGibsonTSampsonJ. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol2014;32:39893995.

    • Search Google Scholar
    • Export Citation
  • 104.

    TravisLBGospodarowiczMCurtisRE. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst2002;94:182192.

    • Search Google Scholar
    • Export Citation
  • 105.

    MorrisLGSikoraAGPatelSG. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol2011;29:739746.

    • Search Google Scholar
    • Export Citation
  • 106.

    KawaguchiTMatsumuraAIuchiK. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy. Jpn J Clin Oncol2006;36:711.

    • Search Google Scholar
    • Export Citation
  • 107.

    RichardsonGETuckerMAVenzonDJ. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med1993;119:383390.

    • Search Google Scholar
    • Export Citation
  • 108.

    JonssonSThorsteinsdottirUGudbjartssonDF. Familial risk of lung carcinoma in the Icelandic population. JAMA2004;292:29772983.

  • 109.

    LiXHemminkiK. Familial multiple primary lung cancers: a population-based analysis from Sweden. Lung Cancer2005;47:301307.

  • 110.

    MatakidouAEisenTHoulstonRS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer2005;93:825833.

    • Search Google Scholar
    • Export Citation
  • 111.

    Bailey-WilsonJEAmosCIPinneySM. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet2004;75:460474.

  • 112.

    ThorgeirssonTEGellerFSulemP. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature2008;452:638642.

    • Search Google Scholar
    • Export Citation
  • 113.

    HungRJMcKayJDGaborieauV. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature2008;452:633637.

    • Search Google Scholar
    • Export Citation
  • 114.

    AmosCIWuXBroderickP. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet2008;40:616622.

    • Search Google Scholar
    • Export Citation
  • 115.

    YangIAHollowayJWFongKM. Genetic susceptibility to lung cancer and co-morbidities. J Thorac Dis2013;5Suppl 5:S454462.

  • 116.

    HwangSJChengLSLozanoG. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet2003;113:238243.

    • Search Google Scholar
    • Export Citation
  • 117.

    SandersBMJayMDraperGJRobertsEM. Non-ocular cancer in relatives of retinoblastoma patients. Br J Cancer1989;60:358365.

  • 118.

    FletcherOEastonDAndersonK. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst2004;96:357363.

  • 119.

    MayneSTBuenconsejoJJanerichDT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol1999;149:1320.

    • Search Google Scholar
    • Export Citation
  • 120.

    SametJMHumbleCGPathakDR. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis1986;134:466470.

  • 121.

    AlavanjaMCBrownsonRCBoiceJDJr.HockE. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol1992;136:623632.

    • Search Google Scholar
    • Export Citation
  • 122.

    Wu-WilliamsAHDaiXDBlotW. Lung cancer among women in north-east China. Br J Cancer1990;62:982987.

  • 123.

    GaoYTBlotWJZhengW. Lung cancer among Chinese women. Int J Cancer1987;40:604609.

  • 124.

    BrennerAVWangZKleinermanRA. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol2001;30:118124.

    • Search Google Scholar
    • Export Citation
  • 125.

    SkillrudDMOffordKPMillerRD. Higher risk of lung cancer in chronic obstructive pulmonary disease: a prospective, matched, controlled study. Ann Intern Med1986;105:503507.

    • Search Google Scholar
    • Export Citation
  • 126.

    YangPSunZKrowkaMJ. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med2008;168:10971103.

    • Search Google Scholar
    • Export Citation
  • 127.

    LowryKPGazelleGSGilmoreME. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: a decision analysis. Cancer2015;121:15561562.

    • Search Google Scholar
    • Export Citation
  • 128.

    YoungRPHopkinsRJ. How the genetics of lung cancer may overlap with COPD. Respirology2011;16:10471055.

  • 129.

    El-ZeinRAYoungRPHopkinsRJEtzelCJ. Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk. Cancer Prev Res (Phila)2012;5:522527.

    • Search Google Scholar
    • Export Citation
  • 130.

    KoshiolJRotunnoMConsonniD. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One2009;4:e7380.

    • Search Google Scholar
    • Export Citation
  • 131.

    YoungRPHopkinsRJChristmasT. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J2009;34:380386.

    • Search Google Scholar
    • Export Citation
  • 132.

    TurnerMCChenYKrewskiD. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med2007;176:285290.

    • Search Google Scholar
    • Export Citation
  • 133.

    Turner-WarwickMLebowitzMBurrowsBJohnsonA. Cryptogenic fibrosing alveolitis and lung cancer. Thorax1980;35:496499.

  • 134.

    HubbardRVennALewisSBrittonJ. Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study. Am J Respir Crit Care Med2000;161:58.

    • Search Google Scholar
    • Export Citation
  • 135.

    HughesJMWeillH. Asbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality study. Br J Ind Med1991;48:229233.

    • Search Google Scholar
    • Export Citation
  • 136.

    HanSSTen HaafKHazeltonWD. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. Int J Cancer2017;140:24362443.

    • Search Google Scholar
    • Export Citation
  • 137.

    McKeeBJHashimJAFrenchRJ. Experience with a CT screening program for individuals at high risk for developing lung cancer. J Am Coll Radiol2015;12:192197.

    • Search Google Scholar
    • Export Citation
  • 138.

    KovalchikSATammemagiMBergCD. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med2013;369:245254.

    • Search Google Scholar
    • Export Citation
  • 139.

    BergCD. Formidable challenges ahead for lung cancer screening. Oncology (Williston Park)2012;26:182185.

  • 140.

    PinskyPFBergCD. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?J Med Screen2012;19:154156.

    • Search Google Scholar
    • Export Citation
  • 141.

    PinskyPFKramerBS. Lung cancer risk and demographic characteristics of current 20-29 pack-year smokers: implications for screening. J Natl Cancer Inst2015;107.

    • Search Google Scholar
    • Export Citation
  • 142.

    MillerDLMayfieldWRLuuTD. Community-based multidisciplinary computed tomography screening program improves lung cancer survival. Ann Thorac Surg2016;101:18641869.

    • Search Google Scholar
    • Export Citation
  • 143.

    KatkiHAKovalchikSABergCD. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA2016;315:23002311.

    • Search Google Scholar
    • Export Citation
  • 144.

    LiKHusingASookthaiD. Selecting high-risk individuals for lung cancer screening: a prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort. Cancer Prev Res (Phila)2015;8:777785.

    • Search Google Scholar
    • Export Citation
  • 145.

    TammemagiMCChurchTRHockingWG. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med2014;11:e1001764.

    • Search Google Scholar
    • Export Citation
  • 146.

    Ten HaafKJeonJTammemagiMC. Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study. PLoS Med2017;14:e1002277.

    • Search Google Scholar
    • Export Citation
  • 147.

    Yousaf-KhanUvan der AalstCde JongPA. Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax2017;72:819824.

    • Search Google Scholar
    • Export Citation
  • 148.

    SaghirZDirksenAAshrafH. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax2012;67:296301.

    • Search Google Scholar
    • Export Citation
  • 149.

    PedersenJHAshrafHDirksenA. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. J Thorac Oncol2009;4:608614.

    • Search Google Scholar
    • Export Citation
  • 150.

    MenezesRJRobertsHCPaulNS. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer2010;67:177183.

    • Search Google Scholar
    • Export Citation
  • 151.

    SwensenSJJettJRHartmanTE. CT screening for lung cancer: five-year prospective experience. Radiology2005;235:259265.

  • 152.

    WilsonDOWeissfeldJLFuhrmanCR. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med2008;178:956961.

    • Search Google Scholar
    • Export Citation
  • 153.

    PinskyPFGieradaDSHockingW. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med2014;161:627633.

    • Search Google Scholar
    • Export Citation
  • 154.

    VarlottoJMDecampMMFlickingerJC. Would screening for lung cancer benefit 75- to 84-year-old residents of the United States?Front Oncol2014;4:37.

    • Search Google Scholar
    • Export Citation
  • 155.

    SoxHC. Better evidence about screening for lung cancer. N Engl J Med2011;365:455457.

  • 156.

    JettJRMidthunDE. Screening for lung cancer: for patients at increased risk for lung cancer, it works. Ann Intern Med2011;155:540542.

    • Search Google Scholar
    • Export Citation
  • 157.

    Berrington de GonzalezAKimKPBergCD. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen2008;15:153158.

    • Search Google Scholar
    • Export Citation
  • 158.

    MarshallHMBowmanRVYangIA. Screening for lung cancer with low-dose computed tomography: a review of current status. J Thorac Dis2013;5Suppl 5:S524539.

    • Search Google Scholar
    • Export Citation
  • 159.

    YipRHenschkeCIXuDM. Lung cancers manifesting as part-solid nodules in the National Lung Screening Trial. AJR Am J Roentgenol2017;208:10111021.

    • Search Google Scholar
    • Export Citation
  • 160.

    GardinerNJogaiSWallisA. The revised lung adenocarcinoma classification-an imaging guide. J Thorac Dis2014;6:S537546.

  • 161.

    NaidichDPBankierAAMacMahonH. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology2013;266:304317.

    • Search Google Scholar
    • Export Citation
  • 162.

    SeidelmanJLMyersJLQuintLE. Incidental, subsolid pulmonary nodules at CT: etiology and management. Cancer Imaging2013;13:365373.

  • 163.

    HansellDMBankierAAMacMahonH. Fleischner Society: glossary of terms for thoracic imaging. Radiology2008;246:697722.

  • 164.

    TravisWDAsamuraHBankierAA. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol2016;11:12041223.

    • Search Google Scholar
    • Export Citation
  • 165.

    TravisWDBrambillaENoguchiM. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med2013;137:668684.

    • Search Google Scholar
    • Export Citation
  • 166.

    TravisWDBrambillaENoguchiM. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol2011;6:244285.

    • Search Google Scholar
    • Export Citation
  • 167.

    KimHYShimYMLeeKS. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology2007;245:267275.

    • Search Google Scholar
    • Export Citation
  • 168.

    YipRYankelevitzDFHuM. Lung cancer deaths in the National Lung Screening Trial attributed to nonsolid nodules. Radiology2016;281:589596.

    • Search Google Scholar
    • Export Citation
  • 169.

    FukuiMSuzukiKMatsunagaT. Surgical intervention for ground glass dominant lesions: observation or outright resection?Jpn J Clin Oncol2017:16.

    • Search Google Scholar
    • Export Citation
  • 170.

    GouldMKDoningtonJLynchWR. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest2013;143:e93S120S.

    • Search Google Scholar
    • Export Citation
  • 171.

    ChangBHwangJHChoiYH. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest2013;143:172178.

  • 172.

    LindellRMHartmanTESwensenSJ. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology2007;242:555562.

    • Search Google Scholar
    • Export Citation
  • 173.

    MacMahonHAustinJHGamsuG. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology2005;237:395400.

    • Search Google Scholar
    • Export Citation
  • 174.

    JacobsCvan RikxoortEMMurphyK. Computer-aided detection of pulmonary nodules: a comparative study using the public LIDC/IDRI database. Eur Radiol2016;26:21392147.

    • Search Google Scholar
    • Export Citation
  • 175.

    ZhaoYde BockGHVliegenthartR. Performance of computer-aided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume. Eur Radiol2012;22:20762084.

    • Search Google Scholar
    • Export Citation
  • 176.

    ArmatoSG3rdMcLennanGBidautL. The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans. Med Phys2011;38:915931.

    • Search Google Scholar
    • Export Citation
  • 177.

    ClarkTJFloodTFMaximinSTSachsPB. Lung CT screening reporting and data system speed and accuracy are increased with the use of a semiautomated computer application. J Am Coll Radiol2015;12:f13011306.

    • Search Google Scholar
    • Export Citation
  • 178.

    JacobsCvan RikxoortEMScholtenET. Solid, part-solid, or non-solid?: classification of pulmonary nodules in low-dose chest computed tomography by a computer-aided diagnosis system. Invest Radiol2015;50:168173.

    • Search Google Scholar
    • Export Citation
  • 179.

    ValenciaRDeneckeTLehmkuhlL. Value of axial and coronal maximum intensity projection (MIP) images in the detection of pulmonary nodules by multislice spiral CT: comparison with axial 1-mm and 5-mm slices. Eur Radiol2006;16:325332.

    • Search Google Scholar
    • Export Citation
  • 180.

    FischbachFKnollmannFGriesshaberV. Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol2003;13:23782383.

    • Search Google Scholar
    • Export Citation
  • 181.

    KawelNSeifertBLuetolfMBoehmT. Effect of slab thickness on the CT detection of pulmonary nodules: use of sliding thin-slab maximum intensity projection and volume rendering. AJR Am J Roentgenol2009;192:13241329.

    • Search Google Scholar
    • Export Citation
  • 182.

    PeloschekPSailerJWeberM. Pulmonary nodules: sensitivity of maximum intensity projection versus that of volume rendering of 3D multidetector CT data. Radiology2007;243:561569.

    • Search Google Scholar
    • Export Citation
  • 183.

    ParkEAGooJMLeeJW. Efficacy of computer-aided detection system and thin-slab maximum intensity projection technique in the detection of pulmonary nodules in patients with resected metastases. Invest Radiol2009;44:105113.

    • Search Google Scholar
    • Export Citation
  • 184.

    JankowskiAMartinelliTTimsitJF. Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection. Eur Radiol2007;17:31483156.

    • Search Google Scholar
    • Export Citation
  • 185.

    RubinGDLyoJKPaikDS. Pulmonary nodules on multi-detector row CT scans: performance comparison of radiologists and computer-aided detection. Radiology2005;234:274283.

    • Search Google Scholar
    • Export Citation
  • 186.

    FraioliFBertolettiLNapoliA. Computer-aided detection (CAD) in lung cancer screening at chest MDCT: ROC analysis of CAD versus radiologist performance. J Thorac Imaging2007;22:241246.

    • Search Google Scholar
    • Export Citation
  • 187.

    SahinerBChanHPHadjiiskiLM. Effect of CAD on radiologists' detection of lung nodules on thoracic CT scans: analysis of an observer performance study by nodule size. Acad Radiol2009;16:15181530.

    • Search Google Scholar
    • Export Citation
  • 188.

    DasMMuhlenbruchGHeinenS. Performance evaluation of a computer-aided detection algorithm for solid pulmonary nodules in low-dose and standard-dose MDCT chest examinations and its influence on radiologists. Br J Radiol2008;81:841847.

    • Search Google Scholar
    • Export Citation
  • 189.

    LeeHYGooJMLeeHJ. Usefulness of concurrent reading using thin-section and thick-section CT images in subcentimetre solitary pulmonary nodules. Clin Radiol2009;64:127132.

    • Search Google Scholar
    • Export Citation
  • 190.

    KuboTLinPJStillerW. Radiation dose reduction in chest CT: a review. AJR Am J Roentgenol2008;190:335343.

  • 191.

    LeeJYChungMJYiCALeeKS. Ultra-low-dose MDCT of the chest: influence on automated lung nodule detection. Korean J Radiol2008;9:95101.

  • 192.

    FunamaYAwaiKLiuD. Detection of nodules showing ground-glass opacity in the lungs at low-dose multidetector computed tomography: phantom and clinical study. J Comput Assist Tomogr2009;33:4953.

    • Search Google Scholar
    • Export Citation
  • 193.

    HeinPARomanoVCRogallaP. Linear and volume measurements of pulmonary nodules at different CT dose levels - intrascan and interscan analysis. Rofo2009;181:2431.

    • Search Google Scholar
    • Export Citation
  • 194.

    van RielSJSanchezCIBankierAA. Observer variability for classification of pulmonary nodules on low-dose CT images and its effect on nodule management. Radiology2015;277:863871.

    • Search Google Scholar
    • Export Citation
  • 195.

    RidgeCAYildirimABoisellePM. Differentiating between subsolid and solid pulmonary nodules at CT: inter- and intraobserver agreement between experienced thoracic radiologists. Radiology2016;278:888896.

    • Search Google Scholar
    • Export Citation
  • 196.

    KimHParkCMSongYS. Measurement variability of persistent pulmonary subsolid nodules on same-day repeat CT: what is the threshold to determine true nodule growth during follow-up?PLoS One2016;11:e0148853.

    • Search Google Scholar
    • Export Citation
  • 197.

    PennAMaMChouBB. Inter-reader variability when applying the 2013 Fleischner guidelines for potential solitary subsolid lung nodules. Acta Radiol2015;56:11801186.

    • Search Google Scholar
    • Export Citation
  • 198.

    PinskyPFGieradaDSNathPH. National lung screening trial: variability in nodule detection rates in chest CT studies. Radiology2013;268:865873.

    • Search Google Scholar
    • Export Citation
  • 199.

    SinghSPinskyPFinebergNS. Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Radiology2011;259:263270.

    • Search Google Scholar
    • Export Citation
  • 200.

    GieradaDSPilgramTKFordM. Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening. Radiology2008;246:265272.

    • Search Google Scholar
    • Export Citation
  • 201.

    HenschkeCIBoffettaPGorlovaO. Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer2011;71:328332.

  • 202.

    van KlaverenRJOudkerkMProkopM. Management of lung nodules detected by volume CT scanning. N Engl J Med2009;361:22212229.

  • 203.

    Lopes PegnaAPicozziGMascalchiM. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer2009;64:3440.

    • Search Google Scholar
    • Export Citation
  • 204.

    VeronesiGBellomiMScanagattaP. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg2008;136:611617.

    • Search Google Scholar
    • Export Citation
  • 205.

    InfanteMCavutoSLutmanFR. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med2009;180:445453.

    • Search Google Scholar
    • Export Citation
  • 206.

    SwensenSJJettJRHartmanTE. Lung cancer screening with CT: Mayo Clinic experience. Radiology2003;226:756761.

  • 207.

    HenschkeCIYankelevitzDFNaidichDP. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology2004;231:164168.

    • Search Google Scholar
    • Export Citation
  • 208.

    HenschkeCIYankelevitzDFMiettinenOSInternational Early Lung Cancer Action Program Investigators. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med2006;166:321325.

    • Search Google Scholar
    • Export Citation
  • 209.

    International Early Lung Cancer Action Program InvestigatorsHenschkeCIYankelevitzDF. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med2006;355:17631771.

    • Search Google Scholar
    • Export Citation
  • 210.

    SteeleJDBuellP. Asymptomatic solitary pulmonary nodules. Host survival, tumor size, and growth rate. J Thorac Cardiovasc Surg1973;65:140151.

    • Search Google Scholar
    • Export Citation
  • 211.

    GalanteEReduzziDGallusG. The growth rate in the interpretation of the natural history of lung cancer. Tumori1984;70:427432.

  • 212.

    UsudaKSaitoYSagawaM. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer1994;74:22392244.

  • 213.

    AraiTKuroishiTSaitoY. Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group. Jpn J Clin Oncol1994;24:199204.

    • Search Google Scholar
    • Export Citation
  • 214.

    WeissWBoucotKRCooperDA. The histopathology of bronchogenic carcinoma and its relation to growth rate, metastasis, and prognosis. Cancer1970;26:965970.

    • Search Google Scholar
    • Export Citation
  • 215.

    PatelVKNaikSKNaidichDP. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm. Chest2013;143:840846.

    • Search Google Scholar
    • Export Citation
  • 216.

    MurrmannGBvan VollenhovenFHMoodleyL. Approach to a solid solitary pulmonary nodule in two different settings-”Common is common, rare is rare”. J Thorac Dis2014;6:237248.

    • Search Google Scholar
    • Export Citation
  • 217.

    AllenTLKendiATMitiekMOMaddausMA. Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer. Semin Thorac Cardiovasc Surg2011;23:4350.

    • Search Google Scholar
    • Export Citation
  • 218.

    SwensenSJViggianoRWMidthunDE. Lung nodule enhancement at CT: multicenter study. Radiology2000;214:7380.

  • 219.

    YiCALeeKSKimBT. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med2006;47:443450.

    • Search Google Scholar
    • Export Citation
  • 220.

    ChristensenJANathanMAMullanBP. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol2006;187:13611367.

    • Search Google Scholar
    • Export Citation
  • 221.

    SchillaciOTravascioLBolacchiF. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients. Radiol Med2009;114:890906.

    • Search Google Scholar
    • Export Citation
  • 222.

    BastarrikaGGarcia-VellosoMJLozanoMD. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med2005;171:13781383.

    • Search Google Scholar
    • Export Citation
  • 223.

    SebroRApariciCMHernandez-PampaloniM. FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease. Ann Nucl Med2013;27:400405.

    • Search Google Scholar
    • Export Citation
  • 224.

    ReyesNOnadekoOOLuraschi-Monjagatta MdelC. Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region. Lung2014;192:589593.

    • Search Google Scholar
    • Export Citation
  • 225.

    HuberHHodolicMStelzmullerI. Malignant disease as an incidental finding at (1)(8)F-FDG-PET/CT scanning in patients with granulomatous lung disease. Nucl Med Commun2015;36:430437.

    • Search Google Scholar
    • Export Citation
  • 226.

    McWilliamsATammemagiMCMayoJR. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med2013;369:910919.

    • Search Google Scholar
    • Export Citation
  • 227.

    HerderGJvan TinterenHGoldingRP. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest2005;128:24902496.

    • Search Google Scholar
    • Export Citation
  • 228.

    PatelVKNaikSKNaidichDP. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest2013;143:825839.

    • Search Google Scholar
    • Export Citation
  • 229.

    GouldMKFletcherJIannettoniMD. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest2007;132:108S130S.

    • Search Google Scholar
    • Export Citation
  • 230.

    MadsenPHHoldgaardPCChristensenJBHoilund-CarlsenPF. Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer. Eur J Nucl Med Mol Imaging2016;43:20842097.

    • Search Google Scholar
    • Export Citation
  • 231.

    Al-AmeriAMalhotraPThygesenH. Risk of malignancy in pulmonary nodules: a validation study of four prediction models. Lung Cancer2015;89:2730.

    • Search Google Scholar
    • Export Citation
  • 232.

    InfanteMCavutoSLutmanFR. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med2015;191:11661175.

    • Search Google Scholar
    • Export Citation
  • 233.

    GieradaDSPinskyPNathH. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst2014;106.

    • Search Google Scholar
    • Export Citation
  • 234.

    YipRHenschkeCIYankelevitzDFSmithJP. CT screening for lung cancer: alternative definitions of positive test result based on the National Lung Screening Trial and International Early Lung Cancer Action Program databases. Radiology2014;273:591596.

    • Search Google Scholar
    • Export Citation
  • 235.

    WoodDEKazerooniEBaumSL. Lung cancer screening, version 1.2015: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw2015;13:2334; quiz 34.

    • Search Google Scholar
    • Export Citation
  • 236.

    KazerooniEAArmstrongMRAmorosaJK. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol2015;12:3842.

    • Search Google Scholar
    • Export Citation
  • 237.

    HenschkeCIYipRYankelevitzDFSmithJPInternational Early Lung Cancer Action Program Investigators. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med2013;158:246252.

    • Search Google Scholar
    • Export Citation
  • 238.

    RevelMPBisseryABienvenuM. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable?Radiology2004;231:453458.

    • Search Google Scholar
    • Export Citation
  • 239.

    RampinelliCOriggiDBellomiM. Low-dose CT: technique, reading methods and image interpretation. Cancer Imaging2013;12:548556.

  • 240.

    DonnellyEF. Technical parameters and interpretive issues in screening computed tomography scans for lung cancer. J Thorac Imaging2012;27:224229.

    • Search Google Scholar
    • Export Citation
  • 241.

    KozowerBDLarnerJMDetterbeckFCJonesDR. Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest2013;143:e369S399S.

    • Search Google Scholar
    • Export Citation
  • 242.

    KimHParkCMKohJM. Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy. Diagn Interv Radiol2014;20:4757.

    • Search Google Scholar
    • Export Citation
  • 243.

    DetterbeckFC. Overdiagnosis during lung cancer screening: is it an overemphasised, underappreciated, or tangential issue?Thorax2014;69:407408.

    • Search Google Scholar
    • Export Citation
  • 244.

    RampinelliCDe MarcoPOriggiD. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ2017;356:j347.

    • Search Google Scholar
    • Export Citation
  • 245.

    WienerRS. Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage. Ann Intern Med2014;161:445446.

    • Search Google Scholar
    • Export Citation
  • 246.

    EttingerDS. Lung cancer screening: has its time come?Oncology (Williston Park)2014;28:342448.

  • 247.

    BraillonA. Bronchioalveolar lung cancer: screening and overdiagnosis. J Clin Oncol2014;32:3575.

  • 248.

    JohnsonDHSchillerJHBunnPA. Reply to A. Braillon. J Clin Oncol2014;32:3575.

  • 249.

    SlatoreCGSullivanDRPappasMHumphreyLL. Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review. J Thorac Oncol2014;9:927934.

    • Search Google Scholar
    • Export Citation
  • 250.

    BrawleyOWFlenaughEL. Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule. Oncology (Williston Park)2014;28:441446.

    • Search Google Scholar
    • Export Citation
  • 251.

    MaJWardEMSmithRJemalA. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer2013;119:13811385.

    • Search Google Scholar
    • Export Citation
  • 252.

    GoldstrawPCrowleyJChanskyK. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol2007;2:706714.

    • Search Google Scholar
    • Export Citation
  • 253.

    Rami-PortaRBallDCrowleyJ. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol2007;2:593602.

    • Search Google Scholar
    • Export Citation
  • 254.

    AminMBGreeneFLEdgeSB eds. AJCC Staging Manual8th ed.New York: Springer International Publishing; 2017.

  • 255.

    Rami-PortaRAsamuraHTravisWDRuschVW. Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin2017;67:138155.

    • Search Google Scholar
    • Export Citation
  • 256.

    FliederDBVazquezMCarterD. Pathologic findings of lung tumors diagnosed on baseline CT screening. Am J Surg Pathol2006;30:606613.

  • 257.

    HallFM. Identification, biopsy, and treatment of poorly understood premalignant, in situ, and indolent low-grade cancers: are we becoming victims of our own success?Radiology2010;254:655659.

    • Search Google Scholar
    • Export Citation
  • 258.

    GareenIFDuanFGrecoEM. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer2014;120:34013409.

    • Search Google Scholar
    • Export Citation
  • 259.

    MetsOMde JongPAProkopM. Computed tomographic screening for lung cancer: an opportunity to evaluate other diseases. JAMA2012;308:14331434.

    • Search Google Scholar
    • Export Citation
  • 260.

    MetsOMBuckensCFZanenP. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA2011;306:17751781.

    • Search Google Scholar
    • Export Citation
  • 261.

    JacobsPCGondrieMJMaliWP. Unrequested information from routine diagnostic chest CT predicts future cardiovascular events. Eur Radiol2011;21:15771585.

    • Search Google Scholar
    • Export Citation
  • 262.

    SekikawaACurbJDEdmundowiczD. Coronary artery calcification by computed tomography in epidemiologic research and cardiovascular disease prevention. J Epidemiol2012;22:188198.

    • Search Google Scholar
    • Export Citation
  • 263.

    SilvestriGA. Screening for lung cancer: it works, but does it really work?Ann Intern Med2011;155:537539.

  • 264.

    CroswellJMBakerSGMarcusPM. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med2010;152:505512W176–580.

    • Search Google Scholar
    • Export Citation
  • 265.

    DiederichSWormannsDSemikM. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology2002;222:773781.

    • Search Google Scholar
    • Export Citation
  • 266.

    GohaganJKMarcusPMFagerstromRM. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer2005;47:915.

    • Search Google Scholar
    • Export Citation
  • 267.

    HenschkeCIMcCauleyDIYankelevitzDF. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet1999;354:999105.

    • Search Google Scholar
    • Export Citation
  • 268.

    KanekoMEguchiKOhmatsuH. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology1996;201:798802.

    • Search Google Scholar
    • Export Citation
  • 269.

    WienerRSSchwartzLMWoloshinSWelchHG. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med2011;155:137144.

    • Search Google Scholar
    • Export Citation
  • 270.

    HenschkeCIYipRYankelevitzDFMiettinenOS. Computed tomography screening for lung cancer: prospects of surviving competing causes of death. Clin Lung Cancer2006;7:323325.

    • Search Google Scholar
    • Export Citation
  • 271.

    McCunneyRJLiJ. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors. Chest2014;145:618624.

    • Search Google Scholar
    • Export Citation
  • 272.

    BachPBJettJRPastorinoU. Computed tomography screening and lung cancer outcomes. JAMA2007;297:953961.

  • 273.

    BachPBCramerLDSchragD. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med2001;345:181188.

  • 274.

    SilvestriGAHandyJLacklandD. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest1998;114:675680.

  • 275.

    StephanFBoucheseicheSHollandeJ. Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest2000;118:12631270.

    • Search Google Scholar
    • Export Citation
  • 276.

    SoneSTakashimaSLiF. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet1998;351:12421245.

  • 277.

    LiFSoneSAbeH. Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings. Radiology2002;225:673683.

    • Search Google Scholar
    • Export Citation
  • 278.

    ArmatoSG3rdLiFGigerML. Lung cancer: performance of automated lung nodule detection applied to cancers missed in a CT screening program. Radiology2002;225:685692.

    • Search Google Scholar
    • Export Citation
  • 279.

    DeVitaVTJr.YoungRCCanellosGP. Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer1975;35:98110.

    • Search Google Scholar
    • Export Citation
  • 280.

    FolkmanJ. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med1995;333:17571763.

    • Search Google Scholar
    • Export Citation
  • 281.

    PatzEFBlackWCGoodmanPC. CT screening for lung cancer: not ready for routine practice. Radiology2001;221:587591.

  • 282.

    YoshizawaAMotoiNRielyGJ. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol2011;24:653664.

    • Search Google Scholar
    • Export Citation
  • 283.

    RussellPAWainerZWrightGM. Does lung adenocarcinoma subtype predict patient survival?: a clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol2011;6:14961504.

    • Search Google Scholar
    • Export Citation
  • 284.

    JettJRMidthunDE. Commentary: CT screening for lung cancer--caveat emptor. Oncologist2008;13:439444.

  • 285.

    BachPB. Reduced lung-cancer mortality with CT screening. N Engl J Med2011;365:2036; author reply 2037–2038.

  • 286.

    van den BerghKAEssink-BotMLBungeEM. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer2008;113:396404.

    • Search Google Scholar
    • Export Citation
  • 287.

    van den BerghKAEssink-BotMLBorsboomGJ. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer2010;102:2734.

    • Search Google Scholar
    • Export Citation
  • 288.

    van den BerghKAEssink-BotMLBorsboomGJ. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J2011;38:154161.

    • Search Google Scholar
    • Export Citation
  • 289.

    GieradaDSPinskyPFDuanF. Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants. Eur Radiol2017;27:32493256.

    • Search Google Scholar
    • Export Citation
  • 290.

    SistromCLDreyerKJDangPP. Recommendations for additional imaging in radiology reports: multifactorial analysis of 5.9 million examinations. Radiology2009;253:453461.

    • Search Google Scholar
    • Export Citation
  • 291.

    BerlandLLSilvermanSGGoreRM. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol2010;7:754773.

    • Search Google Scholar
    • Export Citation
  • 292.

    LarkeFJKrugerRLCagnonCH. Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. AJR Am J Roentgenol2011;197:11651169.

    • Search Google Scholar
    • Export Citation
  • 293.

    BrennerDJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology2004;231:440445.

    • Search Google Scholar
    • Export Citation
  • 294.

    FrankLChristodoulouEKazerooniEA. Radiation risk of lung cancer screening. Semin Respir Crit Care Med2013;34:738747.

  • 295.

    MascalchiMBelliGZappaM. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial. AJR Am J Roentgenol2006;187:421429.

    • Search Google Scholar
    • Export Citation
  • 296.

    GoulartBHBensinkMEMummyDGRamseySD. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw2012;10:267275.

    • Search Google Scholar
    • Export Citation
  • 297.

    Centers for Disease Control and Prevention. Vital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010. MMWR Morb Mortal Wkly Rep2011;60:12071212.

    • Search Google Scholar
    • Export Citation
  • 298.

    MauchleyDCMitchellJD. Current estimate of costs of lung cancer screening in the United States. Thorac Surg Clin2015;25:205215.

  • 299.

    SchweigertMDubeczABeronM. Pulmonary infections imitating lung cancer: clinical presentation and therapeutical approach. Ir J Med Sci2013;182:7380.

    • Search Google Scholar
    • Export Citation
  • 300.

    JacobsPCGondrieMJvan der GraafY. Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer. AJR Am J Roentgenol2012;198:505511.

    • Search Google Scholar
    • Export Citation
  • 301.

    MorganLChoiHReidM. The frequency of incidental findings and subsequent evaluation in low-dose CT scans for lung cancer screening. Ann Am Thorac Soc2017;14:14501456.